Merck Won’t Go Hollywood: In-House R&D Still Focus As Outside Deals Expand
Executive Summary
Merck is on a pace to sign 50 outside R&D alliances during 2003
You may also be interested in...
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Merck Drops Strict “No Merger” Policy, But Still Prefers Licensing Deals
Merck appears to be distancing itself from a blanket "no merger" policy by offering a formula under which it would consider a large-scale transaction
Schering Says Smaller Is Better: Flexibility Aids Turnaround Process
Schering-Plough's smaller size will be an advantage as the company implements its turnaround plan, CEO Fred Hassan told investors during a business briefing in New York Nov. 18